CAH — Cardinal Health Income Statement
0.000.00%
Last trade - 00:00- $37.16bn
- $41.96bn
- $222.58bn
- 70
- 66
- 91
- 90
Annual income statement for Cardinal Health, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | R2022 June 30th | R2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 162,467 | 181,326 | 204,979 | 226,827 | 222,578 |
| Cost of Revenue | |||||
| Gross Profit | 6,778 | 6,484 | 6,874 | 7,414 | 8,168 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 162,009 | 181,943 | 204,227 | 225,584 | 220,303 |
| Operating Profit | 458 | -617 | 752 | 1,243 | 2,275 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 323 | -784 | 663 | 1,201 | 2,101 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 612 | -937 | 331 | 853 | 1,569 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 611 | -938 | 330 | 852 | 1,561 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 611 | -938 | 330 | 852 | 1,561 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.02 | 4.29 | 5.08 | 6.75 | 6.99 |
| Dividends per Share |